We are exploring a new treatment for advanced non-small cell lung cancer using JNJ-86974680 alone and with other therapies. The goal is to see how well it works in combination with cetrelimab and radiotherapy.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced non-small cell lung cancer (NSCLC) is a type of lung cancer that has spread beyond the lungs to other parts of the body, often leading to serious health issues. It is characterized by symptoms such as persistent cough, chest pain, shortness of breath, and weight loss.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.